Warts are benign skin tumors caused by Human Papilloma Virus (HPV). When severe they can be associated with significant morbidity that is frequently underestimated.
Cytovation’s lead candidate CyPep-1 is a first-in-class peptide with a novel mechanism of action and currently in pre-clinical development for the treatment of cutaneous warts.
